Evidence map›Paper›PMID 41299670›Full record

ArticlePilot and feasibility studies2025

High-flow Oxygen and Nitric Oxide inhalation versus high-flow oxygen alone to prevent intubation in hypoxaemic Respiratory failure (HONOR): a pilot randomised controlled trial protocol.

Luke Churchill, Oystein Tronstad, Karen Hay, Peter J Thomas, Kiran Shekar

Abstract read
In one paragraph

Article in Pilot and feasibility studies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Luke ChurchillPhysiotherapy Department, The Prince Charles Hospital, Chermside, Brisbane, QLD, 4032, Australia. Luke.Churchill@health.qld.gov.au.ORCID http://orcid.org/0000-0002-7542-1331
Oystein TronstadPhysiotherapy Department, The Prince Charles Hospital, Chermside, Brisbane, QLD, 4032, Australia.
Karen HayQIMR Berghofer Medical Research Institute, Brisbane, Australia.
Peter J ThomasDepartment of Physiotherapy, Royal Brisbane and Women's Hospital, Brisbane, Australia.
Kiran ShekarAdult Intensive Care Services, The Prince Charles Hospital, Brisbane, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhen conventional oxygen therapies fail, endotracheal intubation and invasive mechanical ventilation are the current standard of care in patients with acute hypoxaemic respiratory failure. However, invasive mechanical ventilation is associated with increased hospital and intensive care length of stay, healthcare costs, and morbidity and mortality. Inhaled nitric oxide has the potential to treat hypoxaemia and potentially prevent the need for invasive mechanical ventilation. AIMS AND

objectivesThe objective of this study is to examine the feasibility and effectiveness of high-flow oxygen and nitric oxide gas inhalation compared with high-flow oxygen alone in preventing invasive mechanical ventilation for patients with acute hypoxaemic respiratory failure.

methodsIn this pilot, randomised controlled feasibility study, 40 patients admitted to the intensive care unit with acute hypoxaemic respiratory failure will be randomised on a 1:1 ratio to receive one of two interventions: high-flow oxygen and nitric oxide gas inhalation (intervention) or high-flow oxygen alone (control) via high-flow nasal cannula. Feasibility, demographic, outcome, and safety data will be collected at several timepoints during participants' admission. DISCUSSION: This protocol outlines a structured method for investigating the effects of inhaled nitric oxide gas in preventing invasive mechanical ventilation for patients with acute hypoxaemic respiratory failure. Considering the risks, costs, and poorer outcomes associated with invasive mechanical ventilation, less invasive means of respiratory support warrant further investigation. The study will assist in planning a larger, multi-centre definitive trial.

trial registrationThis study is registered on the Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12622001411730. Registered 4th September 2022, https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=384881 .

Indexed as

Acute respiratory failureEndotracheal intubationHigh-flow oxygenInhaled nitric oxideInvasive mechanical ventilationOxygen therapy

Identifiers

PMID41299670
PMCPMC12659384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.